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Pumilio/fem-3 mRNA-binding factor (PUF) proteins possess
a recognition code for basesA,U, andG, allowing designedRNA
sequence specificity of their modular Pumilio (PUM) repeats.
However, recognition side chains in a PUM repeat for cytosine
are unknown. Here we report identification of a cytosine-recog-
nition code by screening random amino acid combinations at
conservedRNA recognition positions using a yeast three-hybrid
system.ThisC-recognition code is specific andmodular as spec-
ificity can be transferred to different positions in the RNA rec-
ognition sequence. A crystal structure of a modified PUF
domain reveals specific contacts between an arginine side chain
and the cytosine base. We applied the C-recognition code to
design PUF domains that recognize targets with multiple cyto-
sines and to generate engineered splicing factors that modulate
alternative splicing. Finally, we identified a divergent yeast PUF
protein, Nop9p, that may recognize natural target RNAs with
cytosine. This work deepens our understanding of natural PUF
protein target recognition and expands the ability to engineer
PUF domains to recognize any RNA sequence.
The specific interaction of RNA and protein plays vital roles
in RNA regulation including splicing, localization, translation,
and degradation. Such recognition may be directed toward
unstructuredRNA requiring discrimination of RNA sequences,
folded RNA motifs, or some combination of sequence and
structural specificity (1). Members of the PUF2 protein family
(named after Drosophila Pumilio and Caenorhabditis elegans
fem-3 mRNA-binding factor (FBF)) are sequence-specific
RNA-binding proteins that regulate networks of mRNAs
encoding proteins of related function (2–7). PUF proteins gen-
erally recognize the 3-UTR of their target mRNAs to control
the mRNA stability and translation (2–7).
The RNA-binding domain of PUF proteins, known as the
Pumilio homology domain (PUM-HD) or PUF domain, can
bind to unstructured RNA sequences in a distinct fashion. The
PUF domain of human Pumilio 1 contains eight PUM repeats,
each containing three -helices packed together in a curved
structure (8–10). RNA is bound as an extended strand to the
concave surface of the PUF domain with the bases contacted by
protein side chains. In general, each PUM repeat recognizes a
single RNAbase through the secondhelix (2) in an antiparallel
arrangement, i.e. nucleotides 1–8 are recognized by PUF
repeats 8–1, respectively. The 2 helices of PUM repeats con-
tain a 5-residue sequence, designated here as 12XX5, where the
side chain at position 2 stacks with the recognized base and the
side chains at positions 1 and 5 recognize the edge of the base (8,
11) (see Fig. 1A). Specific residues at these positions direct the
base recognition properties of the repeat. This PUF-RNA rec-
ognition codemakes it possible tomodify a PUM repeat to bind
a particular RNA base, producing a designed PUF domain that
specifically recognizes a given 8-nucleotide RNA target. Such
de novo designed RNA binders have been used to track RNA
localization in cells (12, 13), study PUF protein function (14,
15), andmodulate alternative splicing (16) and continue to pro-
vide a useful tool for biomedical research with possible thera-
peutic applications.
One limitation to application of designed PUF proteins is
that although themodular code for recognition of RNAbasesA,
U, andG has been deduced, a code for cytosine recognition by a
PUMrepeat is unknown.Thus, recognition of a cytosine cannot
be engineered in a repeat, although Pumilio 1 can accept any
base including cytosine at the fifth position of the target
sequence, and yeast Puf3p specifically recognizes a cytosine two
bases upstreamof the core PUF recognition sequence (17).Nat-
urally occurring PUMrepeats that specifically recognize a cyto-
sine have not been identified, providing no clues to a cytosine-
recognition code and uncertainty about whether such specific
recognition exists or is possible. The identification of a combi-
nation of amino acid side chains in a PUM repeat that can
recognize a cytosine is necessary to expand the use of designed
PUF domains directed toward any RNA sequence.
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Using a yeast three-hybrid system, we found that the 5-resi-
due RNA interaction sequence SYXXR allows PUM repeats of
humanPumilio 1 (hereafter referred to as PUF for simplicity) to
specifically interact with cytosine. In a crystal structure of a
complex between a mutant PUF (SYXXR) and cognate RNA,
the arginine side chain interacts directly with the cytosine, and
the serine side chain helps to position the arginine residue. We
applied the recognition code to design new PUF domains to
recognize RNA targets with multiple cytosine residues such as
CUG repeats that are responsible for the pathogenesis of myo-
tonic dystrophy. We also used the code to engineer splicing
factors that modulate alternative splicing of both a splicing
reporter and an endogenous gene. Furthermore, a naturally
occurring yeast PUF protein, Nop9p, appears to contain a
repeat with a code for cytosine and is conserved in homologs
from yeast to human, suggesting that the natural target
sequences of these PUF proteins may contain cytosine.
EXPERIMENTAL PROCEDURES
Generation of a Random Sequence Library—A PUF mutant
library was generated through three PCR amplifications using
primers with randomized regions (supplemental Fig. S1). In
reaction 1, the 5 portion of the Pumilio 1 PUF domain was
amplified from wild-type PUF with primers Bam-Puf-1F (5-
GGA TCC GAG GCC GCA GCC GCC TTT TGG AA) and
Puf-R6N-2R (5-GAT TAC ATA NNN TCC ATA TTG ATC
CTG TAC CAG). In reaction 2, the 3 portion of the PUF
domain was amplified with primers Puf-R6N-1F (5-TATGTA
ATC NNN CAT GTA CTG GAG CAC GGT CG) and Puf-
Xho-2R (5-CTC GAG CCC CTA AGT CAA CAC CGT TCT
TC). The Puf-R6N-2R contains 3 randomnucleotides encoding
the amino acid at position 1043, whereas Puf-R6N-1F contains
random nucleotides encoding the residue at position 1047
(supplemental Fig. S1). The purified PCR products of reactions
1 and 2 were mixed as the template for reaction 3 with primers
Bam-Puf1-1F and Puf-Xho-2R. The final PCR products encode
the entire PUF domain and have the two randomized codons at
positions 1043 and 1047.
Yeast expression plasmid encoding wild-type PUF fused at
the N terminus to the Gal-4 activation domain was created by
amplification of the coding sequence of the PUF domain from
pTYB3-HsPUM1-HD (9) and subcloned into the pACT2 plas-
mid using BamHI and XhoI sites. Plasmids expressing target
RNAsweremade by annealingDNAoligonucleotides encoding
the desired RNAs and subcloning into the pIIIA-MS2-2 plas-
mid using SmaI and SphI restriction sites.
Yeast three-hybrid (Y3H) assays were performed in yeast
strain YBZ-1 as described previously (18, 19). For the Y3H
screen, instead of generating anEscherichia coliplasmid library,
we generated a yeast library screening system directly through
gap repair (supplemental Fig. S1). First, the pIIIA-MS2-2 plas-
mid carrying UGCAUAUA RNA was transformed and
expressed in yeast strain YBZ-1. Second, an EcoRI site was
introduced by site-directed mutagenesis into wild-type
pACT2-PUF between the nucleotides encoding positions 1043
and 1047. The pACT2-PUF-EcoDNA was linearized by EcoRI
and co-transformed with the random PUF PCR library at a
molar ratio 1:6 into the yeast. About 50,000 yeast clones were
generated, giving at least 10-fold coverage of the entire 6-nucle-
otide sequence space (46  4096). Yeast transformants were
screened on plates lacking histidine and containing 10 mM
3-aminotriazole. The transformants that survived HIS growth
selection were confirmed with LacZ expression. Selected yeast
plasmid DNAs were sequenced and reintroduced into mother
strain to confirm the interaction and specificity.
Plasmid Constructs—Additional PUF site-directed mutants
carried by pACT2 were generated using the QuikChange site-
directed mutagenesis kit (Agilent). The pTYB3-PUF mutants
for in vitro protein expression were created by PCR amplifica-
tion from yeast expression plasmids and subcloning into the
pTYB3 plasmid using NcoI and SapI restriction sites. To gen-
erate the engineered splicing factors (ESFs) that recognize
C-containing target sequences, we mutated plasmids encoding
the RS-PUF or Gly-PUF fusion proteins (16).
Liquid -Galactosidase Assays—The activity of -galacto-
sidase was measured using 96-well plates using 12 clones from
each sample (20). The yeast colonies were randomly picked and
inoculated into 12 differentwellswith 100l of culturemedium
in a 96-well plate. After overnight growth in 24 °Cwith shaking,
the culture density of each well was determined by reading
OD650 with a plate-type spectrophotometer (spectroMAX
PLUS from Molecular Devices). In each clone, 25 l of cell
culture was removed and transferred into a new 96-well plate
andmixed with 225l of assay buffer (60mMNa2HPO4, 40mM
NaH2PO4, 1 mM MgCl2, 0.2% (w/v) Sarkosyl, and 0.4 mg/ml
O-nitrophenol--D-galactopyranoside). The plate was incu-
bated at 37 °C for 2 h, and 100 l of 1 M carbonate solution was
added into eachwell to stop the reaction.Wemeasured theA405
with a spectrophotometer to quantify the product (nitrophe-
nol). The -galactosidase units were calculated as the differ-
ence ofA405 between the sample and the background calibrated
by culture densities (20).
Protein Expression, Purification, and Electrophoretic Mobil-
ity Shift Assay (EMSA)—All proteins were expressed in E. coli
strain BL21 and purified as described previously (9, 11). Protein
purity was examined with SDS-PAGE gel electrophoresis. Pro-
tein concentration was determined by Bradford assay. RNAs
were generated by in vitro transcription and purified on dena-
turing gels. 50 pmol of RNAs was labeled at the 3 end with
biotinylated cytidine bisphosphate using T4 RNA ligase follow-
ing the manufacturer’s directions (Thermo Scientific Pierce
RNA3 endbiotinylation kit). In each sample, 20 fmol of labeled
RNA (1 nM) and 4 pmol of proteins (0.2 M) were incubated in
binding buffer (10mMHEPES, pH7.3, 20mMKCl, 1mMMgCl2,
1 mM DTT, and 0.1 g/liter tRNA) for 1 h at room temperature.
The binding reactions were separated by electrophoresis on
6% non-denaturing PAGE run with 1 Tris-borate-EDTA at
4 °C, transferred to nylon membranes, and cross-linked to
the membrane by UV. Biotin-labeled RNA was detected by
chemiluminescence using the Thermo Scientific LightShift
chemiluminescent RNA EMSA kit following the manufac-
turer’s directions.
Crystallization, Structure Determination, and Refinement—
Crystals of PUF-R6(SYXXR) mutant and C3 RNA (5-AUUG-
CAUAUA) were grown by sitting drop vapor diffusion. RNA
oligonucleotide was obtained from Dharmacon (Lafayette,
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CO). The protein-RNAcomplexwas prepared bymixing a 1:1.1
molar ratio of purified protein (3.5 mg/ml) and RNA in a buffer
containing 20 mM Tris-HCl, pH 7.5; 100 mM NaCl; and 1 mM
DTT. One l of complex solution was added to 1 l of a well
solution containing 30% PEG 3350, 0.2 M ammonium tartrate
dibasic, and 0.1 M Bis-Tris, pH 5.5. Crystals were flash-frozen
after adding an equal volume of cryoprotectant solution (32%
PEG 3350, 20% ethylene glycol) to the drop. Diffraction data
were collected at the Southeast Regional Collaborative Access
Team (SER-CAT) beamline ID-22, Advanced Photon Source at
wavelength 1.0 Å and180 °C. All data sets were indexed, inte-
grated, and scaled with the HKL2000 suite (21). The structure
was determined by molecular replacement using the structure
of human Pumilio 1 (Protein Data Bank (PDB) ID: 1M8Y) as a
searchmodel with PHASER (22). Two complexes are present in
the asymmetric unit. Iterative model building was performed
with COOT (23), and the resulting models were refined with
PHENIX (24). All- angles arewithin allowable regions of the
Ramachandran plot. The atomic coordinates and structure fac-
tors have been deposited in the PDB (PDB ID: 2YJY).
Cell Culture, Transfection, RNA Purification, and RT-PCR—
Human embryonic kidney 293T cells or breast cancer MDA-
MB-231 cells were grown in Dulbecco’s modified Eagle’s
medium supplementedwith 10% fetal bovine serum. Cells were
seeded onto 24-well plates and transfected with Lipofectamine
2000 following manufacturer’s directions. The purification of
total RNA and semiquantitative RT-PCR were carried out as
described previously (16).
Bioinformatic Analyses—Two PUF proteins in budding
yeast, Puf2p and Nop9p, were identified by searching the Sim-
ple Modular Architecture Research Tool (SMART) database.
We further searched the Saccharomyces Genome Database
using the BLASTP program with the following queries: 1) the
two natural yeast PUF repeats containing a possible C-recogni-
tion code and 2) all the yeast PUF repeats in which we replaced
the native RNA recognition motifs with SXXXR. Only the two
PUF repeats from Puf2p and Nop9p were identified. We then
used the entire PUF domains of Puf2p and Nop9p as queries to
search the non-redundant protein sequences using Position-
Specific Iterated BLAST (PSI-BLAST) and manually inspected
the positive hits to filter out repeats. A subset of representative
sequences with significant matches was selected to cover a
diverse range of organisms. These sequences were aligned
with ClustalW, and a phylogenetic tree was generated with
Phylowidget.
RESULTS
RandomLibrary Screen for Cytosine Recognition—To select a
PUM repeat that specifically recognizes cytosine, we used a
Y3H system that utilizes co-expression of the PUF domain
fused with the Gal-4 activation domain, an RNA target with an
MS2-binding site, and an MS2-LexA fusion protein (Fig. 1B).
This system can be used to reliablymeasure the relative binding
affinity between RNA and protein (18, 19). For our screening,
we introduced a uridine-to-cytosinemutation at the third posi-
tion of a wild-type PUF target sequence (Fig. 1B).We generated
a PUF domain library with random sequences at the first and
fifth positions of the RNA interaction motif in repeat 6, which
recognizes the third position of the RNA target sequence (Fig.
1, A and C, and supplemental Fig. S1). In control experiments,
co-expression of wild-type PUF and its cognate target sequence
(U3) resulted in activation ofHIS3 and LacZ reporter genes. In
contrast, wild-type PUF cannot recognize the target RNA with
a cytosine at the third position (C3), suggesting that our screen
has a low false positive background (Fig. 1D). Yeast transfor-
mants were screened first for HIS3 expression, and 200 of the
resulting positive clones were reconfirmed with a LacZ activity
assay. Plasmids encoding functional PUFs were recovered from
the doubly positive yeast clones (178 clones), and a subset was
FIGURE 1. Identification of a cytosine-recognition code by yeast three-hybrid screen. A, schematic representation of the interaction between wild-type
PUF and its RNA target sequence (5-UGUAUAUA). Protein repeats are indicated by squares, and RNA bases are indicated by ovals (dashed lines, hydrogen
bonds; parentheses, van der Waals contacts). For library screening, the third RNA base was mutated to cytosine (C3) and served as a new target. Nucleotides
encoding positions 1043 and 1047 of the PUF were randomized in the screened library. B, illustration of the yeast three-hybrid assay used to screen the PUF
library for binding to C3 RNA (5-ugCauaua-3) and to measure the PUF-RNA interaction. The interaction between Gal4-PUF and target RNA fused with
MS2-binding sequence can trigger the expression of both reporter genes, LacZ and HIS3. Gal-4 AD, Gal-4 activation domain. C, sequences of the PUF library with
randomized coding sequences at positions 1043 and 1047. D, validation of the yeast three-hybrid system. The expression of the reporter genes, LacZ (left panel)
and HIS3 (right panel), was measured for yeast expressing wild-type PUF and the wild-type RNA (U3) or the mutated RNA C3. Positive binding was found only
when wild-type PUF and U3 RNA were expressed. The interaction between iron-responsive element RNA (IRESRNA) and iron regulatory protein (IRP) was used
as positive control. E, measurement of specific interactions between PUF domains and RNAs with base substitutions at position 3. Positions of the mutated
amino acids and RNA bases are indicated in the left panel. Protein-RNA binding was measured with the yeast three-hybrid system using liquid -galactosidase
assays. For each sample, 12 colonies were picked, and the experiments were performed in triplicate. The -galactosidase activities relative to that of the
wild-type PUF-U3 RNA pair were plotted to reflect the strength of protein-RNA interaction (right). The -fold increase in binding of the mutant protein to the
cognate base versus the non-cognate base in the wild-type RNA is indicated above the bars. Error bars indicate S.D.
TABLE 1
Nucleotide sequences recovered from the Y3H screen
In total, 20 independent clones were sequenced, and the resulting codons are listed
with the encoded amino acid residue in parentheses. The residue at position 1043
(position 2 in the 5-residue RNA-interaction motif) is tyrosine for all clones. Clone
18 did not have an unambiguous sequence for the first codon (indicating either anA
or C in the second position) and thus was disregarded in our analyses.
AA position 1043 AA position 1047














15 AAT(Asn) TAG (stop)
16 AGT(Ser) AGG(Arg)
17 AGT(Ser) AGA(Arg)
18 A(A C)T(Asn Thr) CGG(Arg)
19 AGT(Ser) AGA(Arg)
20 AGT(Ser) AGG(Arg)
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sequenced to identify amino acid combinations directing cyto-
sine recognition.
Of the 19 unambiguous sequences we obtained, 18 coded for
serine at amino acid position 1043 and arginine at amino acid
position 1047, positions 1 and 5 in the 5-residue RNA interac-
tion motif (Table 1, Fig. 1A). The only exception, clone 15,
contained a stop codon at position 1047 and therefore is
likely a false positive. The 18 clones encoding Ser-1043/Arg-
1047 contained four different serine codons and six arginine
codons, suggesting that our screen adequately covered
sequence space. During revision of this manuscript, a study
reporting the identification of a set of cytosine-specific RNA
recognition side chains ((G/A/S/T/C)XXXR) was published
(25). The more stringent conditions we used (10 mM versus
0.5 mM 3-aminotriazole) may have produced the dominance
of the SYXXR sequence over other sets of side chains with
arginine at the fifth position as seen in this other study (25).
The relative -galactosidase activities for the different sets of
side chains suggest that the SYXXR combination binds most
tightly (18, 25).
To examine the specificity of the newly identified C-rec-
ognition code, we measured the RNA-protein interaction
between PUF domains and RNA targets containing each of
the four bases at the third position (Fig. 1E). We found using
a Y3H assay that wild-type PUF bound only to the natural
target sequence with a U at the third position (U3), and a
mutant protein, PUF-Eco, with an EcoRI site inserted
between positions 1043 and 1047 did not recognize any of
the target RNAs (Fig. 1E). The PUF with Ser-1043/Arg-1047
mutations in repeat 6, PUF-R6(SYXXR), specifically bound
to the C3-containing target with similar affinity as the
PUF-WT protein and U3 RNA (18) and did not recognize
targets with an A3 or G3. We measured residual binding of
PUF-R6(SYXXR) to the wild-type U3 sequence, likely due to
the lack of a stacking side chain (asparagine) in repeat 7 (see
below).
FIGURE 2. The cytosine-recognition code can be transferred to other PUM repeats. A, mutation of PUM repeat 2 to convert its binding specificity to
recognize C7 RNA. Indicated mutations were introduced in repeat 2 (left). Protein-RNA binding measured with the yeast three-hybrid system using -galac-
tosidase activity is shown (right). Wild-type PUF and its cognate target RNA were included in all experiments as controls, and its relative activity was set to 1.
B, mutation of PUM repeat 5 to convert its binding specificity to recognize C4 RNA. Indicated mutations were introduced in repeat 5. C, mutation of PUM repeat
6 to convert its binding specificity to recognize C3 RNA. Indicated mutations, including two different stacking residues, were introduced. D, mutation of PUM
repeat 7 to convert its binding specificity to recognize C2 RNA. Indicated mutations, including two different stacking residues, were introduced. For panels A–D,
the -fold increase in binding of the mutant protein to the cognate base versus the non-cognate base in the wild-type RNA is indicated above the bars.
E, mutation of PUM repeat 3 to convert its binding specificity to recognize C6 RNA. Indicated mutations, including mutation of the base stacking residue of
repeat 4, were introduced. For all panels, the experimental conditions and data analyses are similar to that in panel A. Error bars indicate S.D.
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To further confirm RNA binding, we purified the recombi-
nant PUF protein and used EMSA to demonstrate direct bind-
ing of PUF-R6(SYXXR) to C3 RNA (supplemental Fig. S2).
Given the direct and specific interaction with this in vitro assay,
we conclude that the expression of LacZ was indeed caused by
the direct RNA-protein binding.
The Cytosine-recognition Code Can Be Transferred to Other
PUM Repeats—To examine the modularity of the C-binding
code we identified using PUM repeat 6, we applied the code to
PUM repeats 2 and 5 that normally bind to U7 and A4, respec-
tively. We then tested whether such changes specify cytosine
recognition at the cognate positions (C7 for repeat 2 and C4 for
repeat 5) using the Y3H assay. As predicted, mutation of the
conserved RNA-interacting positions in repeat 2 (positions
899–903 becoming SYXXR) changed binding specificity from
U7 to C7, whereas wild-type PUF did not recognize a C7 RNA
target (Fig. 2A). Unlike PUF-R6(SYXXR), PUF-R2(SYXXR) did
not recognize wild-type U7 RNA sequence.
Similarly,mutations in repeat 5 (C1007S/Q1011Ror SRXXR)
are sufficient to change the binding specificity from A4 to C4,
whereas wild-type PUF does not recognize a C4 target RNA.
Repeat 5 of wild-type PUF has an arginine (Arg-1008) in posi-
tion to stack with the RNA base, and we found that the two
mutations in the edge-interacting side chains were sufficient
for cytosine recognition. Therefore, arginine can serve as the
stacking amino acid residue in the C-binding code. However,
introduction of a third mutation in repeat 5 (SYXXR in posi-
tions 1007–1011) maintained C-binding specificity and may
better prevent binding to A4-containing RNA (Fig. 2B).
Effect of the Stacking Residue on Cytosine Recognition—It has
been shown recently that the identity of the amino acid side
chain that stacks with the RNA base is important for the spec-
FIGURE 3. Designed PUF domains that recognize targets with multiple cytosines. A, diagram showing the mutations in PUM repeats 2 and 6 to recognize
C3C7 RNA (left). Relative protein-RNA binding is shown as in Fig. 2 (right). B, stepwise generation of a PUF mutant (PUF-D) that can bind to (CUG)n repeat RNA.
Diagrams show the mutations in PUM repeats 1, 3, 4, 5, and 6 (center, PUF-D) or in PUM repeats 1, 2, 3, 5, 7, and 8 (right, PUF-E) to recognize (CUG)n repeat RNA.
C, relative protein-RNA binding to WT or (CUG)5 RNA is shown as in Fig. 2. Error bars indicate S.D.
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ificity of PUM repeat-RNA interactions (26). Random and sys-
tematic mutagenesis of stacking residues of C. elegans FBF-2
indicated that a change from wild type in the stacking amino
acid side chain of a PUM repeat can relax binding specificity to
the cognate base and, to a lesser extent, the adjacent base. Tyro-
sine, histidine, and arginine are most commonly found at the
stacking position in PUF repeats in the SMART database
(accessionnumber SM00025) andwere also shown inmutagen-
esis screens and systematic mutagenesis experiments to main-
tain RNA binding of FBF-2 (26). Based on modifications of
repeat 5, we established that arginine can serve as a stacking
side chain for cytosine (Fig. 2B).We therefore further tested the
effects of the identity of the stacking side chain on cytosine
specificity.
We evaluated the effect of stacking side chain identity using
position 1044 in repeat 6 of Pumilio 1,which haswild-typeRNA
interaction motif NYXXQ that recognizes U3.Wemutated the
interaction motif to SHXXR and measured binding of the
mutant protein, PUF-R6(SYXXR), to wild-type U3 and mutant
C3 RNA targets (Fig. 2C). PUF-R6(SHXXR) binds well to RNA
containing C3 and more weakly to U3. When the stacking side
chain is changed to tyrosine, PUF-R6(SYXXR), we see similar
effects. We conclude that specific binding of cytosine can be
achieved with Y/H/R as stacking residue in the cognate repeat.
Another naturally, although uncommonly, occurring side
chain at the stacking position is asparagine, as seen in repeat 7
of wild-type Pumilio 1. This repeat specifically recognizes a G
base with an SNXXE RNA interaction motif, but the side chain
of Asn-1080 is not long enough to form a stacking interaction
withG2 (8, 11). To change the specificity of repeat 7 to cytosine,
the base-interacting residues were mutated initially to Ser-
1079/Arg-1083. However, we found that PUF-R7(SNXXR) did
not bind to target RNAs containing G2 or C2, as judged by Y3H
measurement (Fig. 2D). When we also changed the stacking
residue in repeat 7 to tyrosine (N1080Y), the resulting PUF-
R7(SYXXR) bound strongly to C2 and more weakly to G2 (Fig.
2D). Thus, for cytosine recognition, a side chain forming a
stacking interaction with the RNA base appears required for
binding.
In addition to residues in the cognate repeat, we found that
the identity of the stacking residue in the following repeat,
which also contacts the RNA base, can contribute to the bind-
ing affinity at somepositions.Mostwild-type repeats in Pumilio
1 have tyrosine or arginine as the stacking residue in the follow-
ing repeat, the only exception being repeat 3 with a histidine in
repeat 4. When we tried to transfer the C-binding code to
repeat 3, we found that neither SRXXR nor SYXXR introduced
recognition of the cognate C6 (Fig. 2E). However, mutation of
the following stacking residue to tyrosine (H972Y) allowed rec-
ognition of the C6 target (Fig. 2E).
Designed PUF Domains Recognize Targets with Multiple
Cytosines—To extend our studies of the modularity of the
C-recognition code, we sought to engineer new PUFs that can
recognize multiple C residues in their target RNA sequences.
We first created a PUF to recognize the sequenceUGCAUACA
(C3C7) by combining previously studied modifications in
repeats 2 and 6.We found that only the PUFwith bothmodified
repeats, PUF-R6/R2(SYXXR), but neither the wild-type PUF
nor PUFs with one modified repeat bound to the C3C7
sequence (Fig. 3A). This binding is specific because PUF-R6/
R2(SYXXR) with two modified repeats did not bind to RNAs
with one cytosine (C3U7) or no cytosines (wild-type U3U7) at
cognate positions (Fig. 3A).
We next designed two PUFs that recognize 8-nucleotide signa-
ture sequences in (CUG)n RNA repeats. Expanded (CUG)n RNA
repeats causemyotonicdystrophy type1 (DM1).These toxicRNA
repeats accumulate in the nucleus and sequester alternative splic-
ing factors that normally regulate genes important formuscle and
heart functions, thus leading to thepathogenesis observed inDM1
(27, 28). Through stepwise mutagenesis, we generated two PUF
domains that recognize different frames of (CUG)n repeats.
These proteins could be used to compete the binding of splicing
factors topathogenic (CUG)n repeats. PUF-Dwasdesigned to rec-
ognize UGCUGCUG with five mutated repeats (R1(SRXXE),
R3(SYXXR), R4(SYXXE), R5(NRXXQ), and R6(SYXXR)), and
PUF-E was designed to recognize GCUGCUGC with muta-
tions in six repeats (R1(SYXXR), R2(SYXXE), R3(NRXXQ),
R5(SRXXE), R7(SYXXR), and R8(SYXXE)) (Fig. 3B). We
found that PUF-D and PUF-E bound strongly to a (CUG)5 tar-
get RNA but not to control RNA, whereas wild-type PUF and
intermediate PUFs A to C essentially had no interaction with
the (CUG)5 target (Fig. 3B). The de novo design of (CUG)n-
binding PUFs demonstrates the potential to generate new
RNA-binding scaffolds that may be used for therapeutic
applications.
Crystal Structure of PUF-R6(SYXXR) and Cognate C3-con-
taining RNA—To examine how the side chains forming the
C-recognition code are used to specifically recognize cytosine,
we determined a crystal structure of PUF-R6(SYXXR) in com-
plex with a cognate C3 RNA (5-AUUGCAUAUA-3, supple-
mental Table S1). In the structure, Arg-1047 contacts the O2
and N3 positions of the cytosine (Fig. 4A). Ser-1043 forms a
hydrogen bond with an amino group of the arginine side chain,
assisting in positioning Arg-1047. This interaction is similar to
FIGURE 4. Crystal structure of PUF-R6(SYXXR) in complex with C3 RNA.
A, interaction of PUF-R6(SYXXR) with C3 RNA. A ribbon diagram of interaction
of repeat 6 with C3 base (complex 1 with chain A and C displayed) is shown.
B, interaction of wild-type PUF (NYXXQ) with U3 RNA. A ribbon diagram of
interaction of repeat 6 with U3 base is shown. RNA and base-interacting side
chains are shown as stick models colored by atom type (red, oxygen; blue,
nitrogen; orange, phosphorus). Carbon atoms are colored gray in RNA and
light blue in RNA edge-interacting side chains, and magenta inside chains are
in position to stack with the RNA base. Hydrogen bonds are indicated with
dashed lines. This figure was created with PyMOL.
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the interaction of Asn-1043 andGln-1047 in the wild-type pro-
tein with the Watson-Crick edge of U3 (Fig. 4B), although the
longer arginine side chain requires the cytosine base ring posi-
tion to be shifted slightly away from the RNA-binding surface.
Interaction with only the known base-interacting side chains is
consistent with the ability to transfer C-recognition to other
PUM repeats. The crystal structure also indicates that other
small side chains could occupy the position of Ser-1043 and
that alternate conformations of Arg-1047 can recognize the
cytosine, but the ability of the serine side chain to assist in
positioning the arginine side chainmay produce tighter binding
(25).
Applying the Cytosine-recognition Code to Designed Artificial
Splicing Factors—The PUF domain has been used as an RNA-
binding scaffold to engineer novel protein factors for in vivo
RNA localization (12, 13) and for manipulation of alternative
splicing (16). Previously, we developed ESFs by combining a
designed PUF domain with different splicing modulation
domains to specifically regulate different types of alternative
splicing events (16).
FIGURE 5. Using the cytosine-recognition code to direct engineered splicing factors. A, modulating alternative splicing of a cassette exon in a reporter RNA.
Left, diagram of how the two types of ESFs can affect splicing of a cassette exon. Gly-PUF ESF directed to the exonic target can increase exon inclusion, whereas
the RS-PUF ESF can decrease exon inclusion. Top right, RT-PCR products of splicing reactions; bottom right, quantification of splicing. The splicing reporter gene
and expression vectors for different ESFs were co-transfected at 1:2 ratio into 293T cells. Total RNA was purified 24 h after transfection, and splicing of the test
exon was detected with RT-PCR. The percentage of exon included isoform among all isoforms is represented with PSI value (percentage spliced in). The
transfections were carried out in duplicate, and the means of the PSI value were plotted with the error bars indicating the data range. Significant changes (p
values are 0.04 and 0.01 for lanes 2 and 3 as judged by paired Student’s t test) were observed for ESFs that recognize cognate C-containing target. B, design of
ESFs to target endogenous VEGF-A pre-mRNA splicing. The gene and protein sequences of VEGF-A in the region near the alternative splice sites are shown with
two PUFs recognizing different cytosine-containing sequences (left panel, underlined sequences). To shift the splicing toward anti-angiogenic VEGF-A isoforms,
the cultured MDA-MB-231 cells were transfected with 1 g of expression vectors of Gly-PUF#1 or RS-PUF#2. Total RNA was purified 24 h after transfection to
detect VEGF-A splicing by RT-PCR. The percentages of b isoforms were quantified and are plotted below the gel (left). CTL, control.
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To expand the application of ESFs, we created ESFs that can
target C-containing elements by fusing either the Gly-rich
domain of heterogeneous nuclear ribonucleoprotein A1 or the
RS domain of ASF/SF2 with the PUF-R6(SYXXR) domain that
specifically recognizes UGCAUAUA. We tested this ESF by
co-transfecting 293T cells with plasmids expressing the ESF
and a splicing reporter containing the cognate 8-nucleotide tar-
get sequence in an alternatively spliced cassette exon. Changes
in alternative splicing were analyzed using body-labeled RT-
PCR (Fig. 5A, left panel) (16). As designed, the Gly-PUF-
R6(SYXXR) ESF repressed the inclusion of the cassette exon
containing a UGCAUAUA target sequence, whereas the
RS-PUF-R6(SYXXR) ESF increased exon inclusion (Fig. 5A,
lanes 2 and 3). Splicingmodulation is sequence-specific as con-
trol ESFs with non-cognate PUF domains had little effect on
exon inclusion (Fig. 5A, lanes 4 and 5).
We further designed new ESFs to control the splicing of an
endogenous gene using recognition of a C-containing target
FIGURE 6. Natural PUF proteins with putative cytosine-recognition code. A, alignment and phylogenetic tree of the putative C-recognition PUM repeat in
Nop9p homologs from yeast, plants, filamentous fungi, and protists. The query sequences were selected to maximize the divergence of the species but are
otherwise arbitrary. The Giardia protein EES98274 was the chosen as the outgroup in the phylogenetic tree. B, alignment of the putative C-recognition PUM
repeat in Nop9p homologs from the HomoloGene database. The homologous Volvox carteri protein XP_002952190 was included in the alignment as the
outgroup in the phylogenetic tree. The conserved positions for cytosine recognition were highlighted.
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sequence. We chose to manipulate the alternative splicing of
VEGF-A, an importantmediator of angiogenesis and a key anti-
tumor target. The VEGF-A gene contains eight exons that
undergo extensive alternative splicing to produce multiple iso-
forms (supplemental Fig. S3). One newly discovered class of
isoforms (b isoforms) has anti-angiogenic activity that is oppo-
site to canonical VEGF-A isoforms (29, 30). Most solid cancers
are associated with a switch from the VEGF-A b isoforms to the
pro-angiogenic a isoforms to promote angiogenesis. Thus,
restoring the normal splicing balance to the b isoforms may
have potential as a new anti-VEGF cancer therapy.
The two classes of VEGF-A isoforms are generated by the
alternative use of a 3 splice site (ss) in exon 8 (Fig. 5B). Pro-
angiogenic isoforms are spliced with a proximal 3 ss, and the
anti-angiogenic b isoforms are spliced with a distal 3 ss. The
choice of alternative 3 ss is generally controlled by regulatory
cis-elements between the proximal and distal splice sites and/or
inside the core exonic region. Therefore, we designed new PUF
domains to specifically recognize sequences in these regions.
Two ESFs were designed to modulate VEGF-A alternative
splicing; PUF#1 recognized the sequence GCGGUGAG
between the proximal and distal 3 ss, and PUF#2 recognized
the sequence CUGAUACA downstream of the distal 3 ss (Fig.
5B, left panel, blue sequences). The Gly-PUF#1 ESF should
inhibit splicing of pro-angiogenic isoforms (VEGF-Axxx),
whereas the RS-PUF#2 ESF should promote anti-angiogenic
VEGF-Axxx b isoforms; thus, both should shift VEGF-A splicing
toward the b isoforms.When each ESF was expressed inMDA-
MB-231 cells, we indeed found that either ESF shifted splicing
toward the anti-angiogenic isoforms.
DISCUSSION
The identification of a modular code to recognize cytosine
makes it now possible to design PUF domains to bind any given
sequence and broadens opportunities to create new research
tools and therapeutic reagents. We demonstrated this applica-
tion by developing new ESFs to specifically modulate the alter-
native splicing of VEGF-A, a key regulator of angiogenesis and
cancer growth, and designing PUF domains that recognize
pathogenic CUG repeats. Combined with gene delivery tools,
such artificial proteins can potentially be used as new therapeu-
tic reagents.
The identification of this C-binding motif by selection also
suggests that C-binding repeats exist in natural proteins,
although PUF proteins in human, Drosophila, and C. elegans
with PUM repeats that recognize specifically cytosine have not
been identified. The SMART database includes 4032 PUM
repeats (accession number SM00025) in 600 proteins (31, 32).
Among these PUM repeats, we found two Saccharomyces
cerevisiae PUF proteins, Puf2p and Nop9p, that appear to con-
tain a PUM repeat with RNA-interacting side chains similar to
the C-binding code we identified.
Puf2p interacts preferentially with mRNAs encoding mem-
brane-associated proteins (33). It contains a classical RNA rec-
ognition motif followed by six PUM repeats. Repeat 4 of Puf2p
has an SRXXR RNA interaction motif, but homologs of Puf2p
are restricted to the fungi and the putative C-binding code
(SRXXR) is only found in Puf2p ofVanderwaltozyma polyspora
and S. cerevisiae (supplemental Fig. S4). Other Puf2p homologs
have the sequence ARXXR in cognate positions. Thus, it is
unclear whether repeat 4 of Puf2p is a natural C-binding repeat.
The other protein with a putative C-recognition repeat,
Nop9p, is involved in rRNA processing (34) and is essential for
yeast survival. It has eight PUM repeats with longer intervening
sequences between some repeats than are seen in more typical
RNA-binding PUF proteins. Its PUM repeats are considerably
divergent in sequence from those typically found in PUF pro-
teins with knownRNA recognition specificity. A search of non-
redundant protein sequences with PSI-BLAST suggests that
Nop9p represents an ancient class of eukaryotic proteins with
homologs in fungi, plants, and protists (Fig. 6A). PUM repeat 3
of Nop9p possesses an SHXXR base recognitionmotif, suggest-
ing that this repeatmay recognize cytosine naturally.We found
that 26 of 30 PUM repeat sequences have a putative C-binding
motif (SHXXR) in the conserved RNA-interacting positions
and that three repeats have the motif THXXR, both similar to
the C-binding code identified in our Y3H screen (Fig. 6A). One
exception, theGiardia Pumilio-like protein EES98274,was least
related to the others and was deliberately chosen as the out-
group in calculating a phylogenetic tree.
Nop9p homologs in the National Center for Biotechnol-
ogy Information (NCBI) HomoloGene database, which has
identified homologous proteins in fully sequenced genomes,
indicate that Nop9p belongs to a family of proteins encoded
by diverse eukaryotes, including yeast, fish, plants, flies, and
mammals (Fig. 6B). PUM repeat 3 in 13 of 15 homologs con-
tains a putative C-binding motif of SHXXR or SFXXR (found
in mammalian homologs). Schizosaccharomyces pombe and
mosquito homologs are more divergent and may lack this
repeat or the C-binding code. The sequences of all PUM
repeats in the Nop9p homologs are considerably different
from typical RNA-binding PUF proteins; thus, it remains to
be seen whether this family of proteins binds RNA in the
same manner as Pumilio 1. Our results enrich our apprecia-
tion of the diversity of PUF proteins by identifying the
Nop9p subfamily whose target RNAs remain to be discov-
ered and whose RNA recognition mode is likely to be
distinct.
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